Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

4279 - Intratumoral PD-L1 expression is associated with worse survival of patients with Epstein-Barr virus-associated gastric cancer

Date

09 Sep 2017

Session

Poster display session

Topics

Translational Research;  Gastric Cancer

Presenters

Byung Woog Kang

Citation

Annals of Oncology (2017) 28 (suppl_5): v209-v268. 10.1093/annonc/mdx369

Authors

B.W. Kang, A.N. Seo, I. Lee, S.J. Lee, Y.S. Chae, J.G. Kim

Author affiliations

  • Oncology, Kyungpook National University Hospital, 700-721 - Daegu/KR
More

Resources

Abstract 4279

Background

This study investigated the clinical relevance and prognostic impact of the overall expression of programmed cell death protein ligand-1 (PD-L1) and programmed cell death protein ligand-2 (PD-L2), in patients with Epstein-Barr virus-associated gastric cancer (EBVaGC).

Methods

After reviewing 1318 consecutive cases of surgically resected or endoscopic submucosal dissected gastric cancers, the expression status of PD-L1 and PD-L2 in 120 patients with EBVaGC identified by EBV-encoded RNA in situ hybridization was retrospectively analyzed using immunohistochemistry (IHC). For each IHC marker, positivity was separately in intraepithelial tumor cells (iTu-) and immune cells in the tumor stroma area (str-).

Results

Among 116 eligible patients, 57 (49.1%) and 66 patients (56.9%) were determined as iTu-PD-L1-positive and str-PD-L1-positive, respectively, while 23 (21.6%) and 45 patients (38.8%) were determined as iTu-PD-L2-positive and str-PD-L2-positive, respectively. iTu-PD-L1-positivity was found to be significantly associated with lymph node (LN) metastasis (p=0.012) and a poor disease-free survival (DFS)(P=0.032), yet not overall survival (p=0.482). Meanwhile, str-PD-L1-positivity was correlated with the density of iTu- and str-tumor-infiltrating lymphocytes (TILs)(P=0.003, P=0.004, respectively), yet not the patient outcomes. In contrast, str-PD-L2-positivity was related to a lower T category (P=0.003), absence of LN metastasis (P=0.032) and perineural invasion (P=0.028), and iTu- and str-TILs (P

Conclusions

iTu-PD-L1 expression can be used to predict a poor outcome in patients with EBVaGC, and can represent a rational approach for PD-1/PD-L pathway-targeted immunotherapy.

Clinical trial identification

Legal entity responsible for the study

N/A

Funding

None

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.